Guerbet to highlight new contrast kit at CIRSE

AuntMinnie.com staff writers
Sep 20, 2018

Contrast developer Guerbet plans to showcase Vectorio, a new contrast media kit for diagnostic and interventional imaging, at the upcoming Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress in Lisbon.

Vectorio is a mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid plus an anticancer drug during conventional transarterial chemoembolization (TACE) procedures in adults with intermediate-stage hepatocellular carcinoma. It received the CE Mark in August 2017, the company said.

        An unexpected error occurred: Network error: Response not successful: Received status code 500
      
            [
  {
    "message": "Cannot execute GraphQL operations after the server has stopped.",
    "extensions": {
      "code": "INTERNAL_SERVER_ERROR"
    }
  }
]
Related Stories
Guerbet Logo
Systems
Guerbet
2019 12 18 19 15 2524 Guerbet Rsna 2019 400
Clinical News
Guerbet gets Lipiodol approval in China
2019 12 18 19 15 2524 Guerbet Rsna 2019 400
Clinical News
Guerbet forecasts 30%-35% drop in April sales
2019 12 18 19 15 2524 Guerbet Rsna 2019 400
MRI
Guerbet receives regulatory boost for Dotarem
More in Clinical News
Leo Cancer Care nets $65M to deploy proton therapy system
By AuntMinnie.com staff writers
Stanford Medicine used the system to treat a pediatric brain tumor patient on June 4.
July 8, 2026
Cash Bills
GE HealthCare, Mayo Clinic begin new theranostics trial in Minnesota
By AuntMinnie.com staff writers
First U.S. site to investigate the StarGuide GX SPECT/CT technology.
July 8, 2026
Atom Nuclear Lab Thumb
Philips launches new ultrasound system
By AuntMinnie.com staff writers
The system features AI-powered workflows and is designed for high-volume clinical environments.
July 8, 2026
Alturion
AR-guided localization may sub for CT for early-stage lung cancer
By Amerigo Allegretto
AR-guided localization was noninferior to conventional CT guidance and led to better patient experiences.
July 8, 2026
Lungs 3 D Research 400
Imagion extends collaboration with Siemens on MRI contrast agent
By AuntMinnie.com staff writers
Siemens will provide in-kind expertise and technical support to clinical sites.
July 8, 2026
Ai Handshake
Study backs LDCT lung cancer screening in Singapore
By Will Morton
Lung cancer is the leading cause of cancer death in Singapore, with approximately 48% of cases occurring in individuals who have never smoked.
July 8, 2026
Lungs
New criteria evaluates treatment response in bone metastases
By Will Morton
RECIBM-defined response classifications showed high agreement with established criteria and reclassified 19% of patients.
July 7, 2026
Response Evaluation Criteria in Bone Metastases (RECIBM) and metabolic criteria were used to detect a complete response missed at anatomic assessment. A 76-year-old male patient presented with 1 month of hemoptysis and was diagnosed with small cell lung cancer and bone metastases. Baseline (July 2022) F-18 FDG-PET/CT images (A, maximum intensity projection image; B–E, axial images) demonstrate FDG-avid lesions in the left lamina of the first lumbar vertebra (L1) (straight yellow arrows; maximum standardized uptake value, 2.74; peak standardized uptake value normalized to lean body mass, 1.59) and left ilium (curved yellow arrows; maximum standardized uptake value, 3.68; peak standardized uptake value normalized to lean body mass, 2.28). After seven chemotherapy cycles (December 2022), follow-up PET/CT images (F, maximum intensity projection image; G–J, axial images) show complete metabolic resolution of bony lesions (L1: maximum standardized uptake value, 1.32, and peak standardized uptake value normalized to lean body mass, 0.85; left ilium: maximum standardized uptake value, 1.48, and peak standardized uptake value normalized to lean body mass, 0.82), without apparent osteolytic or osteoblastic changes at CT. Assessment was stable disease (SD) according to the University of Texas MD Anderson Cancer Center (MDA) criteria but complete response (CR) or complete metabolic response (CMR) according to RECIBM, PET Response Criteria in Solid Tumors (PERCIST), and European Organization for Research and Treatment of Cancer (EORTC) criteria. The patient was alive as of September 30, 2025.
CT sign may flag who benefits from subdural hematoma procedure
By Will Morton
Among participants with the “the hyperdense capsule sign,” middle meningeal artery embolization resulted in significant benefits over usual care.
July 7, 2026
Representative axial noncontrast CT images with and without the hyperdense capsule sign (HDCS). The HDCS is defined as a hyperdense capsule layer of linear shape surrounding a subdural hematoma (SDH). (A–D) Images of SDH with the HDCS (arrowheads). (E–H) Images of SDH without the HDCS.
Microbot Medical reports over 100% revenue growth in Q2
By AuntMinnie.com staff writers
The revenue gains follow the full market release of the company's Liberty Endovascular Robotic System.
July 7, 2026
Research Money 400
Cleerly to debut customizable full text reports at SCCT 2026
By AuntMinnie.com staff writers
The new capabilities allow provider teams to configure sections, field order, and headings to match individual clinical workflows.
July 7, 2026
Heart Artificial Intelligence Ai 400
Trice Imaging launches obstetrics reporting tool for fetal medicine
By AuntMinnie.com staff writers
The tool aims to support standardized report turnaround, clinical decisions, and operational efficiency for fetal medicine.
July 7, 2026
Ultrasound Gynecologist 400
VB Spine acquires CT-to-fluoroscopy technology for spine navigation
By AuntMinnie.com staff writers
The CT-Fluoro tech allows surgeons to register a patient's preoperative CT scan using standard fluoroscopic imaging.
July 7, 2026
Vb Spine Logo Purple
Page 1 of 3777
Next Page